SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 31.41 |
| Enterprise Value ($M) | -4.63 |
| Book Value ($M) | 37.94 |
| Book Value / Share | 11.86 |
| Price / Book | 0.83 |
| NCAV ($M) | 32.99 |
| NCAV / Share | 10.31 |
| Price / NCAV | 0.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.04 |
| Return on Assets (ROA) | -0.58 |
| Return on Equity (ROE) | -0.68 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.75 |
| Current Ratio | 5.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 41.13 |
| Assets | 46.08 |
| Liabilities | 8.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -43.03 |
| Net Income | -43.04 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -40.36 |
| Cash from Investing | 51.72 |
| Cash from Financing | 0.28 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Stonepine Capital Management, LLC | 6.00 | ||
| 13D/A | Column Group Iii Gp, Lp | 34.60 | -0.87 | |
| 13G | Ra Capital Management, L.p. | 9.99 | ||
| 13G | Alyeska Investment Group, L.P. | 9.99 | ||
| 13G | Goldman Sachs Group Inc | 7.90 | ||
| 13G/A | BML Investment Partners, L.P. | 0.00 | -100.00 | |
| 13G/A | Regents Of The University Of California | 6.81 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 216 | 734 | 29.43 | |
| 429 | 3,087 | 13.90 | |
| 2,135 | 1,861 | 114.72 | |
| 2,845 | 8,187 | 34.75 | |
| 574 | 2,613 | 21.97 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNTI – Senti Biosciences, Inc. | SONN – Sonnet BioTherapeutics Holdings, Inc. |
| SPRC – SciSparc Ltd. | SXTC – China SXT Pharmaceuticals, Inc. |
| SXTP – 60 Degrees Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io